8-K
filed March 13, 2026, 7:59 PM ET
ticker CNTX
CIK 0001842952
litigation
confidence high
sentiment neutral
materiality 0.60
Context Therapeutics removes classified board and for-cause removal after court-approved settlement
Context Therapeutics Inc.
- Court approved stipulation invalidating 3-year director terms and for-cause removal provisions from charter.
- Certificate of Correction filed with Delaware Secretary of State on March 11, 2026.
- Directors' terms expire at 2026 annual meeting; directors can be removed with or without cause by majority vote.
- Stockholder class action dismissed with prejudice as to plaintiff; court retains jurisdiction over mootness fee.
- 2026 annual meeting set for June 24, 2026; record date April 27, 2026; nominees will serve one-year terms.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001628280-26-017691
- form_type
- 8-K
- ticker
- CNTX
- cik
- 0001842952
- company_name
- Context Therapeutics Inc.
- filed_at
- 2026-03-13T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.502050+00:00
- generated_at
- 2026-05-15T12:40:02.086123+00:00
- sec_items
- ["5.03", "8.01", "9.01"]
- event_type
- litigation
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001628280-26-017691
- json_url
- https://secwatch.observer/filing/0001628280-26-017691.json
- markdown_url
- https://secwatch.observer/filing/0001628280-26-017691.md
- text_url
- https://secwatch.observer/filing/0001628280-26-017691.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1842952/000162828026017691/0001628280-26-017691-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1842952/000162828026017691/cntx-20260311.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
APUS
Apimeds faces hostile takeover attempt by Inscobee; company says consent void, files emergency action
Apimeds Pharmaceuticals US, Inc.
March 26, 2026, 7:59 PM ET
litigation
Items 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: litigation
This filing
On March 11, 2026, the Court approved the Stipulated Judgment, pursuant to which (i) Article V, Section 2 of the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), which provides that the Company’s directors shall serve for a term of three years, and (ii) Article VI, Section 1 of the Charter, which provides that the directors of the Company may be removed from office only for cause, were determined to be invalid and unenforceable.
Comparable filing
Because the Stockholder Consent is invalid, the amendment to the Amended and Restated Bylaws of the Company made in connection with the Stockholder Consent is invalid.
Filing page
SEC filing
CPSH
CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share
CPS TECHNOLOGIES CORP/DE/
June 1, 2026, 9:35 AM ET
other_material
Items 1.01, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
similar materiality
This filing
On March 11, 2026, the Court approved the Stipulated Judgment, pursuant to which (i) Article V, Section 2 of the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), which provides that the Company’s directors shall serve for a term of three years, and (ii) Article VI, Section 1 of the Charter, which provides that the directors of the Company may be removed from office only for cause, were determined to be invalid and unenforceable.
Comparable filing
On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.
Filing page
SEC filing
SAGU
Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE
Shreya Acquisition Group
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
similar materiality
This filing
On March 11, 2026, the Court approved the Stipulated Judgment, pursuant to which (i) Article V, Section 2 of the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), which provides that the Company’s directors shall serve for a term of three years, and (ii) Article VI, Section 1 of the Charter, which provides that the directors of the Company may be removed from office only for cause, were determined to be invalid and unenforceable.
Comparable filing
On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.
Filing page
SEC filing
JPM
JPMorgan issues $3B of 6.100% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series PP
JPMORGAN CHASE & CO
May 7, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
similar materiality
This filing
On March 11, 2026, the Court approved the Stipulated Judgment, pursuant to which (i) Article V, Section 2 of the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), which provides that the Company’s directors shall serve for a term of three years, and (ii) Article VI, Section 1 of the Charter, which provides that the directors of the Company may be removed from office only for cause, were determined to be invalid and unenforceable.
Comparable filing
On May 6, 2026, the Company filed a Certificate of Designations, Powers, Preferences and Rights with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges, qualifications, restrictions and limitations relating to the Series PP Preferred Stock
Filing page
SEC filing
KALA
KALA BIO announces 1-for-50 reverse stock split effective May 8, 2026
KALA BIO, Inc.
May 7, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
similar materiality
This filing
On March 11, 2026, the Court approved the Stipulated Judgment, pursuant to which (i) Article V, Section 2 of the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), which provides that the Company’s directors shall serve for a term of three years, and (ii) Article VI, Section 1 of the Charter, which provides that the directors of the Company may be removed from office only for cause, were determined to be invalid and unenforceable.
Comparable filing
On May 7, 2026, KALA BIO, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation (as amended, the “ Certificate of Incorporation ”) with the Secretary of State of Delaware to effect a 1-for-50 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p.m. (Delaware time) on May 8, 2026 (the “ Reverse Stock Split ”).
Filing page
SEC filing
BNZI
Banzai announces 1-for-20 reverse stock split effective May 8, 2026 to maintain Nasdaq compliance
Banzai International, Inc.
May 6, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
similar materiality
This filing
On March 11, 2026, the Court approved the Stipulated Judgment, pursuant to which (i) Article V, Section 2 of the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), which provides that the Company’s directors shall serve for a term of three years, and (ii) Article VI, Section 1 of the Charter, which provides that the directors of the Company may be removed from office only for cause, were determined to be invalid and unenforceable.
Comparable filing
On April 28, 2026, the Company filed a Certificate of Amendment to its COI with the Secretary of State of Delaware (the “Certificate of Amendment”), for the Reverse Stock Split at a ratio of 1-for-20.
Filing page
SEC filing
ATVK
Ameritek renamed GlobalTek; strategy shifts to batteries, robotics, aerospace, luxury housing
Globaltek Ventures, Inc.
May 6, 2026, 7:59 PM ET
other_material
Items 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
similar materiality
This filing
On March 11, 2026, the Court approved the Stipulated Judgment, pursuant to which (i) Article V, Section 2 of the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), which provides that the Company’s directors shall serve for a term of three years, and (ii) Article VI, Section 1 of the Charter, which provides that the directors of the Company may be removed from office only for cause, were determined to be invalid and unenforceable.
Comparable filing
On April 15, 2026, GlobalTek Ventures, Inc. (formerly Ameritek Ventures, Inc.) (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Nevada (Filing Number 20265675229) to change the Company's corporate name from “Ameritek Ventures, Inc.” to “GlobalTek Ventures, Inc.”
Filing page
SEC filing
MTNE
CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE
CH4 Natural Solutions Corp
May 5, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 7.01, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
similar materiality
This filing
On March 11, 2026, the Court approved the Stipulated Judgment, pursuant to which (i) Article V, Section 2 of the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Charter”), which provides that the Company’s directors shall serve for a term of three years, and (ii) Article VI, Section 1 of the Charter, which provides that the directors of the Company may be removed from office only for cause, were determined to be invalid and unenforceable.
Comparable filing
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company’s Amended and Restated Memorandum and Articles of Association (as so amended, the “ Memorandum and Articles ”) were approved on April 30, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.